Cándido Gutiérrez-Panizo

Dr. Cándido Gutiérrez-Panizo


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2025 in Animals
Verified
Journal Article
Open access
PDF file
Marta Matas-QuintanillaMarta Matas-Quintanilla
Marta Matas-Quintanilla
LWLynsey Whitacre
Lynsey Whitacre
IIIgnacio Ipharraguerre
Ignacio Ipharraguerre
CGCándido Gutiérrez-Panizo
Cándido Gutiérrez-Panizo
AGAna Gutiérrez
Ana Gutiérrez
This study arises from the search for non-invasive diagnostic alternatives for equine gastric ulceration (EGUS), which is prevalent, clinically variable and only confirmed by gastroscopy. The aim is to quantify five salivary biomarkers (IL1-F5, PIP, CA VI, serotransferrin, albumin) under clinical conditions by validated assays and analyse their diagnostic value. Horses were grouped in No EGUS (neither clinical signs of EGUS nor gastric lesions), EGUS non-clinical (apparently no clinical signs of EGUS but with gastric lesions), and EGUS clinical (obvious clinical signs of EGUS and with gastric lesions). The concentration of 5 analytes could be quantified using sandwich ELISA assays, with high precision (CV: 6.79–12.38%) and accuracy (>95%). Mean salivary levels of IL1-F5, CA-VI, serotransferrin and albumin were significantly higher in EGUS clinical horses compared to No EGUS horses, whereas PIP showed no statistical significance. EGUS non-clinical horses showed statistical differences with No EGUS horses for PIP and albumin. In addition, IL1-F5, CA-VI, serotransferrin and albumin showed moderate accuracy to distinguish between No EGUS and EGUS clinical horses (AUC ≥ 0.8), with sensitivity and specificity greater than 77% and 65%, respectively. Therefore, these biomarkers could be a promising starting point for screening horse that might have EGUS in practice.

24 September 2026 in Animals
Verified
Journal Article
Open access
PDF file
Marta Matas-QuintanillaMarta Matas-Quintanilla
Marta Matas-Quintanilla
Cristina Castillo RodríguezCristina Castillo Rodríguez
Cristina Castillo Rodríguez
LWLynsey Whitacre
Lynsey Whitacre
IIIgnacio Ipharraguerre
Ignacio Ipharraguerre
CGCándido Gutiérrez-Panizo
Cándido Gutiérrez-Panizo
AGAna Gutiérrez
Ana Gutiérrez
Gastric ulceration is common in horses and remains challenging to diagnose, as gastroscopy is the gold standard. This study aimed to characterise the salivary and serum protein changes associated with a feed-deprivation protocol. Eight horses underwent this protocol, and gastric lesions were assessed by gastroscopy at the end of the experimental period. Saliva and blood samples were collected pre- and post-protocol, and pooled samples from each biological fluid and condition were analysed by two-dimensional gel electrophoresis to compare protein profiles. Fifteen salivary and five serum proteins showed differential abundance and were identified using mass spectrometry. Nine proteins were subsequently validated by Western blotting in individual samples, confirming the proteomic findings. The validated proteins are involved in multiple pathways, including inflammatory and immune responses (interleukins 1-F5 and -F6, prolactin-inducible protein, alpha-1-antitrypsin), metabolic and transport processes (albumin, serotransferrin, apolipoprotein A-IV, fatty acid-binding protein 5), and mucosal protection mechanisms (carbonic anhydrase VI, apolipoprotein A-IV, prolactin-inducible protein, fatty acid-binding protein 5). Compared with serum, saliva showed a more dynamic post-protocol proteomic response, with more proteins displaying altered abundance, supporting its versatility as a non-invasive matrix. Overall, these findings characterise salivary and serum responses associated with the feed-deprivation protocol in horses with gastric lesions confirmed post-protocol.